Avaleht/Aktsiad/ENTX

ENTX

USD

Entera Bio Ltd. Ordinary Shares

$2.100-0.090 (-4.110%)

Reaalajas hind

Healthcare

Biotehnoloogia

Iisrael

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$2.190

Kõrge

$2.280

Madal

$2.040

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

95.4M

Tööstusharu

Biotehnoloogia

Riik

Israel

Kauplemisstatistika

Keskmine maht

0.04M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.41Praegune $2.100Kõrge $2.79

Seotud uudised

15. apr 2025 · 12:30

GlobeNewswire

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced highlights from Dr. Rachel B Wagman's oral

Vaata rohkem

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

28. märts 2025 · 20:05

GlobeNewswire

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business

Vaata rohkem